| # | Drug | Count |
|---|---|---|
| 0 | MONTELUKAST SODIUM | 11 |
| 1 | PANTOPRAZOLE | 11 |
| 2 | TACROLIMUS | 11 |
| 3 | MONTELUKAST | 10 |
| 4 | PREDNISONE | 10 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 6 | TACROLIMUS OINTMENT 0.1% | 9 |
| 7 | ADALIMUMAB | 7 |
| 8 | QUETIAPINE | 5 |
| 9 | SIROLIMUS | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN RABIES VIRUS IMMUNE GLOBULIN | 1 | 0.0156 |
| 1 | LEBRIKIZUMAB-LBKZ | 1 | 0.0004 |
| 2 | SIROLIMUS | 5 | 0.0004 |
| 3 | AMISULPRIDE | 2 | 0.0003 |
| 4 | PENTOSAN POLYSULFATE SODIUM | 1 | 0.0001 |
| 5 | PEGVALIASE-PQPZ | 1 | 0.0001 |
| 6 | VORTIOXETINE | 2 | 0.0001 |
| 7 | FLUTICASONE PROPIONATE NASAL | 3 | 0.0001 |
| 8 | MONTELUKAST SODIUM | 11 | 0.0001 |
| 9 | GOLIMUMAB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Leukotriene Receptor Antagonist [EPC] | 10 | 0.0003 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |
| 3 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 4 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 5 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Influenza A M2 Protein Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 8 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |